The Global Artificial Tears Market was at USD 2.84 billion in 2022, and it is foreseen to reach USD 3.99 billion by 2027 at a CAGR of 5.80% between 2022 and 2027.
Artificial Tears is also known as ocular lubricants. They are used to add moisture and remove eye surface discomfort, for dry eyes. Dry Eyes syndrome causes irritation, burning, heightened eye surface inflammation, irritation, tear in eye film and discomfort for human eyes. Artificial Tears does not have natural proteins as real tears but is composed of water, salts and polymers. This composition helps Artificial tears to acts as an alternative for real tears and prevents dry eyes. Contact lenses uses Artificial tears for moistening and eye drops having Artificial tears, are available in pharmacies.
The Artificial Tears is anticipated to rise further in market, globally. Increase in level of air pollution, vitamin deficiency, climate change, prolonged exposure to blue light emitted from smartphones and long digital workloads hours has resulted in rise of patients suffering from dry eye syndrome. This is boosting the growth of Artificial Tears market. Also rise in geriatric population is demanding more market for contact lenses.
Market Drivers & Restraints
Drivers
The increase in automation and technological advancement in electronic is luring consumers to utilize such electronic devices for continuous hours. This will lead to spike in Dry Eye syndrome and eye diseases. Also, air pollution is severe in developed and developing countries causing harm to eye sight.
Restraints
Certain Eye drops available in market are causing side effects. This is mainly due to preservatives being used in Eye drops. Manufacturers are developing more increased production of eye drops without, preservatives content. The Research and Development in eye drops is a slow process, this is a threat to new developed eye drops available in retail pharmacy, online pharmacy, hospital pharmacy and drug stores.
REPORT METRIC | DETAILS |
Market Size Available | 2022 – 2027 |
Base Year | 2022 |
Forecast Period | 2022 – 2027 |
CAGR | 5.80% |
Segments Covered | By Type, Delivery Mode, Application, End Users Age Group, and Region |
Revenue Forecast by 2027 | USD 3.99 Billion |
Regions Covered | North America, Europe, APAC, RoW |
Market Leaders Profiled | Johnson & Johnson (USA), Bausch + Lomb (USA), Abbott Medical Optics Inc. (USA), Entod Research Cell U.K. Ltd. (UK), Rohto Pharmaceutical Co. Ltd. (Japan), Novartis International AG (Switzerland), Otsuka Pharmaceutical Co. Ltd. (Japan), AFT Pharmaceuticals (New Zealand), Oasis Medical Inc. (USA), Santen Pharmaceutical Co. Ltd. (Japan), and Others. |
CLICK HERE TO DOWNLOAD SAMPLE
Market Segmentation Analysis
In human body there are major five senses which are Sound, Smell, Sight, Taste and Touch. Sight sense is provided through organs named eyes. From eye sight human body receives sensory information to brain. This global report on artificial tears market can be segmented and sub-segmented into the following categories:
Glycerin derived tears is the largest shareholder as compared with other types of Artificial Tears in global market. This product is cheaper and helps to keep eyes moist for longer duration. Glycerin derived tears is also easily available in pharmacy and hospitals. By usage of Glycerin derived tears eyes feel more refresh. Cellulose Derived Tears is expected to flourish further in Artificial Tears Market, globally. The main reason for this factor is increase in shift of End user towards usage of natural-based products.
Eye Drops captures the highest shares in delivery mode for Artificial Tears, in Market. Artificial Tears are easily and commercially available in greater forms as Eye Drops. The Artificial Tears eye drops are considered as first line treatment therapy for Dry Eye Syndrome.
Dry Eyes treatment captures the largest shares for Application of Artificial Tears, in market. According to associated press releases, Dry Eyes is the most recurrent cause of loss of eyesight in patients. Contact Lenses Moisture is projected to grow further for Application of Artificial Tears in market. The major adopters for Contact lenses are users in age group of 20 To 40 Years. The usage of Contact lenses by these users is due the utilization of more electronic devices like computer, phones and etc., for prolonged hours.
The End User group of Above 60 Years captured the largest share for End Users Age Group in Artificial Shares market. According to several press releases, men and women over 50 years of age were affected by medical condition for dry eyes. 20 To 40 Years mainly comprises of teens, who have larger risk of having dry eyes. This is mainly due to the factor that eyes of teens are greatly exposed to blue light emission from digital screens, long hours usage of mobile phone, high dry weather conditions and increase in air pollution levels. The growth of Artificial Tears in global market is from significant rise, in demand from men and woman under age group, of 40 To 60 Years.
Major fluctuations in product pricing and demand along with significant disruptions in supply chains were resulted from the Covid-19 pandemic effect. According to market experts, during pandemic the general market has gained enormous traction. To control the ongoing Covid-19 global crisis, general population is ordered by government to follow social distancing. This will help to control further spread of virus. Routine daily activities such as official work, meeting and schooling have all began to take place online. These online activities are supported with many electrical devices such as computer screens and smartphones. Increased digital workload and long hours exposure to blue light have risked the rise in several eye disorders and generated increase in demand for eyecare products like Artificial Tears and, specifically eyedrops. Thus, the rise in demand for Artificial Tears during SARS-2, pandemic has driven the market growth, globally.
Regional Analysis
North America is anticipated capture the largest shares in Artificial Tears market, globally. This is due to the factor that there is a large number of dry eye based medical patients and its treatments, in this region. In 2022, more than seventeen million adults in USA were diagnosed with dry eye syndrome and eye diseases, according to American Journal of Ophthalmology.
Europe region is estimated to capture second largest shares in Artificial Tears market, globally. The increase in dry eye diseases, ophthalmic disorders, and occurrence of diabetic eye in European countries has generated more demand for Artificial Tears.
Asia-Pacific Region is expected to flourish further Artificial Tears market, globally. Countries like India and China are increasing in population and has more than one third of world population, till date. The rise in dry eye syndrome patient from digital workload is increasing demand for contact lenses in Asia pacific region. The geriatric population is in larger number of countries like China and Japan and India, which is propelling demand for Artificial tears.
Key Companies
The key players in contribution to Artificial Tears Market, globally consists of many. Some of them include Johnson & Johnson (USA), Bausch + Lomb (USA), Abbott Medical Optics Inc. (USA), Entod Research Cell U.K. Ltd. (UK), Rohto Pharmaceutical Co. Ltd. (Japan), Novartis International AG (Switzerland), Otsuka Pharmaceutical Co. Ltd. (Japan), AFT Pharmaceuticals (New Zealand), Oasis Medical Inc. (USA), Santen Pharmaceutical Co. Ltd. (Japan), and Others.
Artificial Tears Market – Forecast (2021-2026)
Chapter 1. Artificial Tears Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Artificial Tears Market - Executive Summary
2.1. Market Size & Forecast – (2021 – 2026) ($M/$B)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2021 - 2026
2.3.2. Impact on Supply – Demand
2.3.3. Impact on Production Cost
2.3.4. Impact on Supply Chain
Chapter 3. Artificial Tears Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier – Distributor Analysis
Chapter 4. Artificial Tears Market Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3. Customer Analysis
4.4. Porters Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Artificial Tears Market Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Artificial Tears Market, By Type - - Market Size, Forecast, Trends & Insights
6.1. Glycerin Derived Tears
6.2. Cellulose Derived Tears
6.3. Polyethylene glycol & Propylene glycol based artificial tears
6.4. Sodium Hyaluronate Based Tears
6.5. Oil based Emulsion Tears
6.6. Others
Chapter 7. Artificial Tears Market, By Delivery Mode - - Market Size, Forecast, Trends & Insights
7.1. Eye Drops
7.2. Ointments
Chapter 8. Artificial Tears Market, By Application - - Market Size, Forecast, Trends & Insights
8.1. Dry Eyes Treatment
8.2. Contact Lenses Moisture
Chapter 9. Artificial Tears Market, By End Users Age Group - - Market Size, Forecast, Trends & Insights
9.1. 20 to 40 Years
9.2. 41 to 60 Years
9.3. Above 60 Years
Chapter 10. Artificial Tears Market, By Geography - Market Size, Forecast, Trends & Insights
10.1. North America
10.1.1. U.S.A
10.1.2. Canada
10.1.3. Mexico
10.2. Europe
10.2.1. Italy
10.2.2. Spain
10.2.3. Russia
10.2.4. Germany
10.2.5. UK
10.2.6. France
10.2.7. Rest of Europe
10.3. Asia Pacific
10.3.1. Japan
10.3.2. South Korea
10.3.3. China
10.3.4. India
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. South America
10.4.2. Middle East
10.4.3. Africa
Chapter 11. Artificial Tears Market - Company Profiles – (Overview, Product Portfolio, Financials, Developments)
11.1. Company 1
11.2. Company 2
11.3. Company 3
11.4. Company 4
11.5. Company 5
11.6. Company 6
11.7. Company 7
11.8. Company 8
11.9. Company 9
11.10. Company 10
2500
4250
5250
6900
Analyst Support
Every order comes with Analyst Support
Customization
We offer customization to cater your needs to fullest
Verified Analysis
We value Integrity, quality and authenticity the most